Biospace

Published September 18, 2026 · Updated September 20, 2026

Electra lights up with $350M IPO for pivotal immune-disease drug development - BioSpace

Read the full story at Biospace

Electra Therapeutics has exceeded its initial fundraising plans as it becomes the 26th biotech to debut publicly this year and outlines pivotal.